Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
629 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07102797 | ActiveGirls: Physical Activity, Hormone Health, and Diabetes Risk in Early Adolescence | recruiting | N/A | 40 | Massachusetts General HospitalOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT07227623 | A Digital Health Intervention to Improve Physical Function and Wellness of Lung Cancer Survivors | recruiting | N/A | 250 | Massachusetts General HospitalOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT02886065 | A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM | active not recruiting | Phase 1 | 19 | Massachusetts General HospitalOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT06807086 | Efficacy of Synchronous, Virtual Cognitive Behavioral Therapy for Insomnia Across Phases of Cancer Survivorship | recruiting | N/A | 198 | Massachusetts General HospitalOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT03223779 | Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer | completed | Phase 1 / Phase 2 | 52 | Massachusetts General HospitalOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT07364474 | Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver | recruiting | N/A | 10 | Massachusetts General HospitalOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT01758042 | Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders(BMT) | completed | N/A | 10 | Massachusetts General HospitalOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT02975869 | A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia | completed | N/A | 160 | Massachusetts General HospitalOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT03535545 | Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients | recruiting | Phase 1 | 100 | Massachusetts General HospitalOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT03830320 | Positron Emission Tomography (PET) Imaging of Thrombosis | recruiting | Phase 1 | 165 | Massachusetts General HospitalOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT03919175 | Umbralisib and Rituximab as Initial Therapy for Patients With Follicular Lymphoma and Marginal Zone Lymphoma | terminated | Phase 2 | 18 | Massachusetts General HospitalOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT04485286 | Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury | recruiting | Phase 2 | 72 | Massachusetts General HospitalOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT07095517 | Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors(PROSPECT) | recruiting | Phase 1 | 20 | Massachusetts General HospitalOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT05465408 | Culturally Aware AET Non-Initiation Intervention | completed | N/A | 35 | Massachusetts General HospitalOTHER | 1 | Feb 24, 2026 | clinicaltrials |
| NCT05898594 | Lung Cancer Screening in High-risk Black Individuals | recruiting | N/A | 900 | Massachusetts General HospitalOTHER | 1 | Feb 23, 2026 | clinicaltrials |
| NCT01858025 | Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma | completed | Early Phase 1 | 25 | Massachusetts General HospitalOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT02833610 | A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency | completed | Phase 2 | 55 | Massachusetts General HospitalOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT05096715 | Atezolizumab+Bevacizumab+SBRT in Unresectable HCC | recruiting | Phase 1 | 20 | Massachusetts General HospitalOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT06027515 | Esophageal Cancer Multimodal Prehabilitation Study | completed | N/A | 15 | Massachusetts General HospitalOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT02718833 | A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma | active not recruiting | Phase 2 | 52 | Massachusetts General HospitalOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT04701918 | Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma | completed | Phase 2 | 9 | Massachusetts General HospitalOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT07355335 | Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML | not yet recruiting | Phase 1 | 24 | Massachusetts General HospitalOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT07358195 | Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation | not yet recruiting | Early Phase 1 | 3 | Massachusetts General HospitalOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT02312102 | Velcade and Lenalidomide in Patients With Relapsed AML and MDS After Allogeneic Stem Cell Transplantation | completed | Phase 1 | 22 | Massachusetts General HospitalOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT04842266 | IlluminOss Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pelvis Fractures | recruiting | — | 100 | Massachusetts General HospitalOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT06472869 | Assessing E-Cigarettes for Tobacco Harm Reduction in the Context of Lung Cancer Screening | completed | N/A | 15 | Massachusetts General HospitalOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT05922501 | Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma(ISABELA) | recruiting | Phase 2 | 50 | Massachusetts General HospitalOTHER | 1 | Jan 14, 2026 | clinicaltrials |
| NCT06172907 | A Dyadic Intervention for Young Adult Patients With Cancer and Their Partner Caregivers(YAD) | recruiting | N/A | 20 | Massachusetts General HospitalOTHER | 1 | Jan 12, 2026 | clinicaltrials |
| NCT03042689 | Study of Regorafenib in Patients With Advanced Myeloid Malignancies | completed | Phase 1 | 16 | Massachusetts General HospitalOTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT04644211 | Ruxolitinib in Thrombocythemia and Polycythemia Vera | recruiting | Phase 2 | 60 | Massachusetts General HospitalOTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT04872738 | Patient Experiences With the COVID-19 Vaccination After Breast Cancer Treatment(LymphVAX) | completed | — | 714 | Massachusetts General HospitalOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT04091009 | Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms | withdrawn | Phase 4 | 0 | Massachusetts General HospitalOTHER | 0 | Dec 31, 2025 | clinicaltrials |
| NCT05714644 | Community Collaboration to Advance Racial/Ethnic Equity in CRC Screening(CARES) | completed | N/A | 5,127 | Massachusetts General HospitalOTHER | 1 | Dec 26, 2025 | clinicaltrials |
| NCT07283848 | Zimberelimab + Domvanalimab in Gastroesophageal Adenocarcinoma | withdrawn | Phase 2 | 0 | Massachusetts General HospitalOTHER | 1 | Dec 26, 2025 | clinicaltrials |
| NCT01521741 | Prospective Screening for Breast Cancer-related Lymphedema | recruiting | — | 10,000 | Massachusetts General HospitalOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT03406208 | Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing | completed | N/A | 228 | Massachusetts General HospitalOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT03285412 | CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer(LEADER) | active not recruiting | Phase 2 | 120 | Massachusetts General HospitalOTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT01407198 | Nilotinib With Radiation for High Risk Chordoma | completed | Phase 1 | 23 | Massachusetts General HospitalOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT01858168 | Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma | completed | Phase 1 | 49 | Massachusetts General HospitalOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT05976490 | NeuroPathways Intervention for Brain Tumor Patients | recruiting | N/A | 50 | Massachusetts General HospitalOTHER | 1 | Dec 17, 2025 | clinicaltrials |
| NCT02314364 | A Trial of Integrating SBRT With Targeted Therapy in Stage IV Oncogene-driven NSCLC | completed | Phase 2 | 27 | Massachusetts General HospitalOTHER | 1 | Dec 16, 2025 | clinicaltrials |
| NCT07219537 | A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule | recruiting | N/A | 30 | Massachusetts General HospitalOTHER | 1 | Dec 16, 2025 | clinicaltrials |
| NCT01358058 | Proton Radiation Therapy for Gliomas | active not recruiting | N/A | 63 | Massachusetts General HospitalOTHER | 1 | Dec 10, 2025 | clinicaltrials |
| NCT06004167 | Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T) | completed | N/A | 10 | Massachusetts General HospitalOTHER | 1 | Dec 9, 2025 | clinicaltrials |
| NCT02378597 | Resiliency Program for Medical Interpreters(CARE) | completed | N/A | 28 | Massachusetts General HospitalOTHER | 0 | Dec 5, 2025 | clinicaltrials |
| NCT02394769 | ASPirin Intervention for the REDuction of Colorectal Cancer Risk(ASPIRED) | active not recruiting | N/A | 180 | Massachusetts General HospitalOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT04830046 | Covid-19 Vaccine Responsiveness in MM and Waldenstrom | completed | — | 146 | Massachusetts General HospitalOTHER | 1 | Nov 26, 2025 | clinicaltrials |
| NCT05346380 | Near-Infrared Perfusion During Minimally Invasive Thoracic Surgery Download | completed | Phase 1 / Phase 2 | 38 | Massachusetts General HospitalOTHER | 1 | Nov 26, 2025 | clinicaltrials |
| NCT01961713 | Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy | recruiting | — | 200 | Massachusetts General HospitalOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT01961843 | Abiraterone Acetate for Castrate Resistant Prostate Cancer | completed | N/A | 40 | Massachusetts General HospitalOTHER | 1 | Nov 25, 2025 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials